InspireMD, Inc.
(NASDAQ : NSPR)

( )
NSPR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -1.28%533.101.0%$618.34m
DHRDanaher Corp. -0.19%296.940.7%$603.21m
ABTAbbott Laboratories -0.07%120.890.8%$560.55m
ISRGIntuitive Surgical, Inc. 0.11%992.552.3%$465.79m
MDTMedtronic Plc -0.08%131.200.6%$454.04m
ALGNAlign Technology, Inc. 0.60%700.006.3%$438.65m
DXCMDexCom, Inc. -0.81%511.357.8%$340.82m
SYKStryker Corp. -0.32%270.071.3%$321.58m
NURONeuroMetrix, Inc. -11.95%13.127.7%$310.14m
BSXBoston Scientific Corp. 0.68%45.911.0%$298.35m
AAgilent Technologies, Inc. -0.14%153.021.6%$282.13m
EWEdwards Lifesciences Corp. 0.82%113.190.4%$282.12m
BDXBecton, Dickinson & Co. 0.16%256.171.0%$254.21m
IDXXIDEXX Laboratories, Inc. 0.03%678.723.8%$252.50m
BAXBaxter International, Inc. -0.23%77.171.8%$212.69m

Company Profile

InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.